Follicular lymphoma trials in India

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  Where

  Delhi, Gurugram, Kolkata, Nashik, Surat, Thiruvananthapuram

  Age

  18 years to 130 years

  People

  1,018 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06549595 · EU 2023-510098-33-01
• Phase 3Taking people
  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  Where

  Bengaluru, Hyderabad, Mumbai, New Delhi

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Celgene

  See details and how to joinNCT06911502 · EU 2024-519152-82-00
• Phase 1Taking people
  A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

  Where

  Ahmedabad, Amravati, Belagavi, Bhubaneswar, Chandigarh, Delhi, Hyderabad, Kochi, Kolhāpur, Kolkata, Mumbai, Nagpur, Nashik, Pune, Rohtak, Srinagar, Surat, Thane, Visakhapatnam

  Age

  18 years to 99 years

  People

  40

  Run by

  Aurigene Discovery Technologies Limited

  See details and how to joinNCT05984147